One‐Year Effectiveness Study of Intravitreous Ranibizumab in Wet (Neovascular) Age‐Related Macular Degeneration: A Meta‐Analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|38|2|197-204

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.38, Iss.2, 2018-02, pp. : 197-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implementation studies of ranibizumab for neovascular age‐related macular degeneration

By  

ACTA OPHTHALMOLOGICA, Vol. 92, Iss. 1, 2014-02 ,pp. : 98-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

An epidemiological study of neovascular age-related macular degeneration in Germany

By Krause Lothar   Yousif Tarik   Pohl Karin    

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1391-1397

Informa Healthcare

Access to resources Recommend Favorite

Is aspirin use associated with age‐related macular degeneration? A meta‐analysis

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 40, Iss. 2, 2015-04 ,pp. : 144-154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison between Aflibercept, Ranibizumab intravitreal injection on Neovascular Age‐related macular degeneration patients

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab

By Mitchell Paul  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1465-1475

Informa Healthcare

Access to resources Recommend Favorite